[ORGANIZATION]
Karyopharm Therapeutics Inc.
Featured in 1 tracked story · first seen
Situations
NeOnc Technologies NEO100 clinical trial progress
2 clusters · 6 sources · last updated
Latest: NeOnc Technologies reports positive Phase 2a data for NEO100
NeOnc Technologies Holdings announced plans to present topline results from the Phase 2a portion of its NEO100-01 clinical trial, which evaluates the safety and efficacy of intranasal NEO100 in patients with recurrent or